Demetrios L. Kouzoukas - 22 Sep 2022 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role
Director
Signature
/s/ Jamie L. Reynoso, Attorney-in-Fact for Demetrios L. Kouzoukas
Issuer symbol
CLOV
Transactions as of
22 Sep 2022
Net transactions value
$0
Form type
4
Filing time
26 Sep 2022, 18:01:25 UTC
Next filing
05 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLOV Class A Common Stock Options Exercise +25,608 25,608 22 Sep 2022 Direct F1
transaction CLOV Class A Common Stock Award $0 +20,271 +79% $0.000000 45,879 22 Sep 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLOV Restricted Stock Unit Options Exercise $0 0 22 Sep 2022 Class A Common Stock 25,608 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration.
F2 Represents shares of Class A common stock underlying a time-based RSU. One hundred percent of the RSUs will vest on the first anniversary of the Date of Grant, subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such date.
F3 One hundred percent of the shares subject to the RSU award vested on the date of the 2022 Annual Meeting.

Remarks:

Exhibit List 24.1-Power of Attorney EXHIBIT LIST: EX-24 Power of Attorney Demetrios L. Kouzoukas, GRAPHIC Power of Attorney Demetrios L. Kouzoukas